Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L37 pseudogene 10 (RPL37P10) is a processed pseudogene in the human genome, located on chromosome 2, that is homologous to the protein-coding RPL37 gene. Unlike the functional RPL37 gene—which encodes a component of the 60S ribosomal subunit involved in protein synthesis—RPL37P10 does not produce a functional protein product. Pseudogenes such as RPL37P10 arise from gene duplication or retrotransposition events and typically lack biological function, coding potential, or relevance as drug targets. This is not considered a therapeutic target, as it is a pseudogene without evidence of expression of a functional protein or established biological/medical role. RPL37P10 is a non-functional genomic sequence; it is not an active, protein-coding target and does not meet the criteria for molecules typically categorized as drug targets, receptors, enzymes, or transporters—this makes it inappropriate for conventional target-based drug discovery. There is no evidence in curated databases or scientific literature for any biological function, disease association, drug interaction, mechanism of action, biomarker potential, or safety concern specific to RPL37P10. All available evidence classifies it solely as a nonfunctional genomic element. RPL37P10 is one of many processed pseudogenes in the human genome related to ribosomal protein genes. It is homologous to RPL37, a gene encoding a constituent of the ribosomal large subunit, but lacks exons and regulatory regions required for expression of a functional protein. As such, it is considered biologically inert and not relevant for therapeutic targeting or disease biomarker development. If you require information about the functional protein (RPL37), see entries under "Ribosomal protein L37" instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L37 pseudogene 10 (RPL37P10).